Exactech (NASDAQ: EXAC) and Syneron Medical (NASDAQ:ELOS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Insider & Institutional Ownership

64.6% of Exactech shares are held by institutional investors. Comparatively, 69.2% of Syneron Medical shares are held by institutional investors. 28.3% of Exactech shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Exactech and Syneron Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exactech 0 0 1 0 3.00
Syneron Medical 0 1 1 0 2.50

Syneron Medical has a consensus price target of $11.00, suggesting a potential upside of 0.00%. Given Syneron Medical’s higher probable upside, analysts clearly believe Syneron Medical is more favorable than Exactech.

Earnings & Valuation

This table compares Exactech and Syneron Medical’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Exactech $262.96 million 1.84 $43.51 million $0.04 847.71
Syneron Medical N/A N/A N/A ($0.12) -91.66

Exactech has higher revenue and earnings than Syneron Medical. Syneron Medical is trading at a lower price-to-earnings ratio than Exactech, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Exactech has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Comparatively, Syneron Medical has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.

Profitability

This table compares Exactech and Syneron Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Exactech 0.30% 7.39% 5.98%
Syneron Medical -1.09% -1.74% -1.30%

Summary

Exactech beats Syneron Medical on 7 of the 10 factors compared between the two stocks.

About Exactech

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

About Syneron Medical

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company’s products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.